INFU (InfuSystem Holdings, Inc.) Stock Analysis - Hedge Fund Holdings
InfuSystem Holdings, Inc. (INFU) is a publicly traded Healthcare sector company. As of May 21, 2026, INFU trades at $10.06 with a market cap of $179.62M and a P/E ratio of 26.47. INFU moved +5.38% today. Year to date, INFU is +15.19%; over the trailing twelve months it is +66.56%. Its 52-week range spans $4.61 to $11.04. Analyst consensus is strong buy with an average price target of $15.83. Rallies surfaces INFU's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns INFU stock?
Hedge funds tracked by Rallies that own INFU include Panagora Asset and Mangrove Partners. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for InfuSystem Holdings, Inc..
INFU Key Metrics
Key financial metrics for INFU
Metric
Value
Price
$10.06
Market Cap
$179.62M
P/E Ratio
26.47
EPS
$0.38
Dividend Yield
0.00%
52-Week High
$11.04
52-Week Low
$4.61
Volume
0
Avg Volume
0
Revenue (TTM)
$142.40M
Net Income
$7.91M
Gross Margin
56.75%
Top Hedge Funds Holding INFU
Panagora Asset holds 82.79K shares of INFU, changed +26.39% as of Mar 31, 2026.
Mangrove Partners holds 74.06K shares of INFU, changed +0.00% as of Mar 31, 2026.
Hedge funds tracked by Rallies that own INFU include Panagora Asset and Mangrove Partners. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for InfuSystem Holdings, Inc..
Does Rallies show 13F holders for INFU?
Yes. Rallies tracks hedge fund and 13F ownership data for INFU, including fund names, share counts, latest tracked quarter, and position changes when available.
Is INFU research on Rallies investment advice?
No. Rallies provides research, data, and educational context for INFU. It does not provide personalized investment advice.